Skip to main content
Clinical Trials/NCT04191876
NCT04191876
Completed
Not Applicable

Financial Incentives to Improve Medication Adherence: a Pilot Study

Northwell Health1 site in 1 country25 target enrollmentNovember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Northwell Health
Enrollment
25
Locations
1
Primary Endpoint
Change in medication adherence rate
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Medication adherence is a challenge in all of medicine and is associated with multiple negative outcomes. Strategies to better measure and enhance adherence to medication are urgent and necessary to minimize unwanted health outcomes, hospitalizations, poorer quality of life and excessive costs for individuals, insurers and caregivers. Recently, behavioral economics-based approaches have emerged as a promising tool to address this unmet need, but its effectiveness in oral antipsychotic treatment remains to be assessed. For this project, investigators will use an app that offers financial incentives to increase compliance for patients with chronic diseases. Investigators intend to enroll 25 patients in a pilot project to assess feasibility of offering financial incentives to improve medication adherence in severe mental illness.

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
March 2, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Psychiatric patients with suspected or confirmed poor oral medication adherence.
  • Age 18-80 years old
  • English speaking, since the app being used is only available in English
  • Owning a Smartphone, since the app requires a Smartphone to work
  • Willing and able to participate.

Exclusion Criteria

  • Acute anger to self or others as per investigator assessment
  • Unwilling or unable to participate

Outcomes

Primary Outcomes

Change in medication adherence rate

Time Frame: Between baseline and study completion (10 weeks)

Adherence rate will be measured as pills missed/pills prescribed

Study Sites (1)

Loading locations...

Similar Trials